Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Introduction In their lifetime, patients with follicular lymphoma frequently require multiple
treatments, which have improved their survival over the past few decades. The expected …

Background The optimal initial therapy of follicular lymphoma (FL) remains unclear. The
aims of this study were to compare primary treatment strategies and assess the impact of …

The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …

Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is
rituximab‐containing chemoimmunotherapy followed by rituximab maintenance. This …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Disease overview: Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Follicular lymphoma (FL) is the most common indolent non‐Hodgkin lymphoma in the
Western hemisphere. The natural history of FL appears to have been favorably impacted by …